Moscow laboratory “Invitro” start testing for coronavirus infection COVID-19. As in Novosibirsk, it acts as a centralized laboratory. The laboratory accepts biomaterials obtained from patients in Moscow clinics and hospitals, and will perform up to 1000 tests per day.
Laboratory and diagnostic uses complex test system of the Russian producer JSC “Vector-best”. The test system has high sensitivity of detection of RNA of the coronavirus SARS-CoV-2 – 1×10*3 copies/ml of the original sample and specificity of 100%. To assess analytical specificity of the manufacturer’s tests were conducted with potentially interfering viruses (influenza A and b, parainfluenza, adenovirus infection, respiratory syncytial infection, metapneumovirus infection, rhinovirus infection and coronavirus infection of man, caused by hCov NL63, hCov OC43, hCov 229E, hCov HKUI) and microorganisms (Streptococcus pneumoniae, Haemophilus influenzae, Streptococcus pyogenes, Staphylococcus aureus). Cross-reacting viruses and microorganisms were found.
Part of the premises clinical diagnostic laboratory translated into a special mode of operation thus to provide an efficient and secure for the employees the process of working with samples. Was allocated premises and equipment, prepared the required number of personal protective equipment, employees have received special training and will only perform this type of studies, 7 days a week.
As previously reported, testing for the coronavirus group “Invitro” is part of the system of measures of state and national health system in the fight against the pandemic. Significant technological, organizational and human resources group is aimed at conducting research on the coronavirus as a centralized laboratory. At the same time a rejection of the capture of biomaterials in medical offices, the company will eliminate an additional risk factor and provides a safe environment for all patients during visits to medoviy “Invitro”. The need for urgent and immediate laboratory diagnosis remains unchanged even in the current difficult epidemiological conditions.